From: Free triiodothyronine predicts the risk of developing diabetic kidney disease
eGFR (ml/min/1.73m2) | Albuminuria staging | ||||||
---|---|---|---|---|---|---|---|
A1 (UACR < 30 mg/g) | A2 (UACR30~300mg/g) | A3 (UACR > 300 mg/g) | Total n(%) | ||||
G1 (≥ 90) | 226 (50.0%) | 77 (17.0%) | 29 (6.4%) | 332 (73.5%) | |||
G2 (60~89) | 38 (8.4%) | 29 (6.4%) | 11 (2.4%) | 78 (17.3%) | |||
G3a (45~59) | 3 (0.7%) | 11 (2.4%) | 8 (1.8%) | 22 (4.9%) | |||
G3b (30~44) | 0 (0.0%) | 2 (0.4%) | 8 (1.8%) | 10 (2.2%) | |||
G4 (15~29) | 0 (0.0%) | 1 (0.2%) | 8 (1.8%) | 9 (2.0%) | |||
G5 (< 15) | 0 (0.0%) | 0 (0.0%) | 1 (0.2%) | 1 (0.2%) | |||
Total n(%) | 267 (59.1%) | 120 (26.5%) | 65 (14.4%) | 452 (100.0%) |